Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03092856
Title Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications

renal cell carcinoma

Therapies

Axitinib

Axitinib + PF-04518600

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles County-USC Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
USC Norris Oncology/Hematology-Newport Beach Newport Beach California 92663 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of Kansas Cancer Center Kansas City Kansas 66160 United States Details
Weill Cornell Medical College, New York- Presbyterian Hospital New York New York 10065 United States Details
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland Ohio 44195 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field